OvationLab
Richmond, Virginia, 23220, United States
Location status: Recruiting
NCT Number: NCT07408245
The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed by SimplyPERIO (Spectrum Solutions, Salt Lake City, UT).
Interested in participating?
Request Info25 year and older
All sexes
Interventional
Not applicable
Richmond, Virginia, 23220, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Broad-spectrum botanical liquid formula
Time frame: Measured at baseline and conclusion of 2-week study
SimplyPERIO - Oral biofilm microorganism test results are categorized as "low", "medium", and "high".
Contact information is provided by the study sponsor or research team.
OvationLab
Network
Prospective Human Study Evaluating the Effects of Biocidin Liquid on Oral Biofilms: An Open-label Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07391748
Biofilm, Biofilm Formation
View Trial DetailsNCT07165054
Biofilm, Endothelial Dysfunction
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04247438
Biofilm, Dental Deposits
Dresden, Saxony, Germany
View Trial DetailsNCT02845726
Biofilm, Morbidity
Sankt Gallen, Canton of St. Gallen, Switzerland
View Trial Details